Rimoin has been working in the DRC since 2002, where she founded the UCLA-DRC Health Research and Training program to train U.S. and Congolese epidemiologists to conduct high-impact infectious disease research in low-resource, logistically-complex settings.

Dr. Rimoin’s research focuses on emerging and vaccine preventable diseases. It has led to fundamental understandings of the epidemiology of human monkeypox in post-eradication of smallpox, long term immunity to Ebolavirus in survivors and durability of immune response to Ebola virus vaccine in health workers in DRC. Her current research portfolio includes studies of COVID-19, Ebola, Marburg, Monkeypox and vaccine preventable diseases of childhood.

Rimoin’s expertise in emerging infectious disease and science communication have made her a regular on-camera subject-expert for local, national, and international news media outlets. Throughout the pandemic she has been a steady and trusted source of information on local Los Angeles news affiliates, national networks, cable news, and current affairs programs. She has also appeared in several public service announcements. Her expertise is regularly featured and often quoted in print media on issues surrounding COVID-19, Monkeypox, and other emerging infections in print media including The Los Angeles Times, The New York Times, The Washington Post, and The Wall Street Journal.

Dr. Rimoin earned her BA at Middlebury College, MPH at UCLA, and PhD at Johns Hopkins University. She started her career in global public health in as a Peace Corps Volunteer in Benin, West Africa in the Guinea Worm Eradication Program.  She has been recognized for her achievements in the fields of Epidemiology and Global Health with the Middlebury College Alumni Achievement Award (2017), induction as a Fellow of the American Society of Tropical Medicine and Hygiene (2019) and the Johns Hopkins Alumni Association Global Achievement Award (2022).